ASKA Pharmaceutical Holdings Co., Ltd. had a revenue of 17.55B in the quarter ending Dec 31, 2024, with 9.59%. This bring the company's revenue in the last twelve months to 63.95B, Decreased 0.60%. In the fiscal year ending Mar 31, 2024, ASKA Pharmaceutical Holdings Co., Ltd. had annual revenue of 62.84B with 3.94% growth.